華髮股份(600325.SH)擬捐贈不超7400萬元支持抗擊新型冠狀病毒肺炎疫情
格隆匯2月19日丨華髮股份(600325.SH)公佈,自新型冠狀病毒肺炎疫情爆發以來,公司高度關注疫情進展,積極落實中共中央、國務院防控疫情工作精神。在做好公司疫情防控及經營管理的同時,作為國有控股上市公司,為切實履行社會責任,根據公司《對外捐贈管理制度》的相關規定,公司董事局決定在不超過7400萬元的額度內(含過去十二個月已捐贈金額)向各地疾控系統、醫療機構及慈善機構等進行捐贈(包括但不限於捐贈現金、防疫物資等方式),用於支持新型冠狀病毒肺炎疫情的防控及救治工作。在上述捐贈額度內,授權公司經營班子具體決定每筆捐贈對象、捐贈方式及數量。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.